Back to homepage


Xeroderma pigmentosum: an updated review

Authors: Alexander KC Leung, Benjamin Barankin, Joseph M Lam, Kin Fon Leong, Kam Lun Hon

This narrative review aims to familiarize physicians with the clinical features, diagnosis and management of xeroderma pigmentosum.


Thalidomide and discoid lupus erythematosus: case series and review of literature

Authors: Giovanna Malara, Chiara Verduci, Maria Altomonte, Maria Cuzzola, Caterina Trifirò, Cristina Politi, Giovanni Tripepi

This article reports four cases of discoid lupus erythematosus treated previously with the most common immunomodulatory agents with no results and finally successfully treated with thalidomide.


Experience with bilastine in the management of urticaria: Original Real-world cases of Bilastine In Treatment (ORBIT) in Asia

Authors: Wai Kwong Cheong, Alson Wai Ming Chan, Chin Chwen Ch’ng, Wen Hung Chung, Ma Teresita Gabriel, Kiran Godse, Wat Mitthamsiri, Hao Trong Nguyen, Marysia Tiongco-Recto, Dinesh Nagrale

These case studies of urticaria aim to capture the long-term use of bilastine in a range of patient types from across the Asia-Pacific region supported by evidence-based literature.


Therapies for hidradenitis suppurativa: a systematic review with a focus on Brazil

Authors: Maria Cecilia Rivitti-Machado, Renata Ferreira Magalhães, Roberto Souto da Silva, Gleison V Duarte, Fabiana ZS Bosnich, Roberto Gaspar Tunala, Francisco José Forestiero

This article is a systematic review to assess current medical therapies for hidradenitis suppurativa with a special focus on Brazil.


Portuguese recommendations for the treatment of atopic dermatitis with biologic therapy and JAK inhibitors in adult patients

Authors: Tiago Torres, Margarida Gonçalo, Maria João Paiva Lopes, Cristina Claro, Leonor Ramos, Manuela Selores, Pedro Mendes Bastos, Joana Rocha, Rodrigo Carvalho, Alberto Mota, Paulo Filipe on Behalf of the Atopic Dermatitis Group of the Portuguese Society of Dermatology and Venereology

This article presents recommendations developed by the Atopic Dermatitis Group of the Portuguese Society of Dermatology and Venereology addressing several clinical questions that arise in the management and care of moderate-tosevere atopic dermatitis with biologic agents and Janus kinase inhibitors based on the available evidence.